RxDoctor Payments Data

Kenneth Williams, DPM

Primary Podiatric Medicine · San Antonio, TXNPI 1740285329

Payments from drug & device makers

What this record shows

This record is dominated by other: $21,000 of the $25,615 with a category attached, or 82.0%. Convatec Inc. accounts for 82.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $21,037 and has fallen 98.0% since, to $416 in 2025. Among primary podiatric medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,615in general payments, 2019–2025

Across 81 payments — averaging $316.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$21K
  • Triad Life Sciences Inc.$3K
  • Treace Medical Concepts, Inc.$982
  • Smith+Nephew$354
  • Stryker$219
  • Orthofix Medical, Inc.$101
  • plus $201 from 8 others

What the payments were for

  • Travel & lodging$2,52910%
  • Food & beverage$2,0868%
  • Other$21,00082%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,615 in reported general payments places this provider in the 95th percentile of 36 primary podiatric medicine providers in Texas.

See all primary podiatric medicine providers in Texas

Medicare billing

Part B allowed, 2024
$90,859
Medicare patients
378
Services billed
1,572

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole11$721
Clotrimazole11$371

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →